|
Aravis Venture Associates AG (Aravis Ventures) |
|
Switzerland |
+41 (61) 466-1000 |
Series B |
|
|
|
Bio*One Capital Pte Ltd |
|
Singapore |
|
Series B |
|
|
|
Lacuna LLC |
|
United States |
+1 (303) 447-1700 |
Series B |
|
|
|
Mitsui & Co Global Investment Inc (三井グループ) |
|
United States |
|
Venture |
|
|
|
Novartis Services Inc (Novartis Venture Fund) |
|
United States |
+1 (617) 871-3536 |
N/A |
|
|
|
Novartis Services Inc (Novartis Venture Fund) |
|
United States |
+41 (61) 324-3714 |
N/A |
|
|
|
Tragara Pharmaceuticals Inc |
Development of proprietary drugs for the treatment of cancer and inflammation-related disorders. |
United States |
+1 (858) 350-6900 |
Other |
|
|
|
Tragara Pharmaceuticals Inc |
Development of proprietary drugs for the treatment of cancer and inflammation-related disorders. |
United States |
+1 (760) 208-6900 |
Other |
|
|
|
Tragara Pharmaceuticals Inc |
Development of proprietary drugs for the treatment of cancer and inflammation-related disorders. |
United States |
(760) 208-6900 |
Other |
|
|
|
Tragara Pharmaceuticals Inc |
Development of proprietary drugs for the treatment of cancer and inflammation-related disorders. |
United States |
(858) 350-6900 |
Other |
|
|
|
ZKB Start-up Finance |
|
Switzerland |
|
Series B |
|
|